TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
LBT Innovations Limited ( (AU:CC5) ) has shared an announcement.
Clever Culture Systems Ltd announced the successful passing of all resolutions at their 2025 Annual General Meeting. The resolutions, which included the re-election of a director and approval of securities issuance, were overwhelmingly supported by proxy votes. This outcome reflects strong shareholder confidence and positions the company for continued growth and innovation in the microbiology automation industry.
More about LBT Innovations Limited
Clever Culture Systems (CCS) is a company based in Adelaide, South Australia, specializing in intelligent automation solutions for microbiology laboratories. Their flagship product, the Automated Plate Assessment System (APAS® Independence), utilizes artificial intelligence and machine learning to automate the imaging, analysis, and interpretation of microbiology culture plates. This technology is the only US FDA-cleared AI technology for automated culture plate reading, marketed to pharmaceutical manufacturing and clinical laboratories for environmental monitoring and infectious disease diagnostics. Thermo Fisher Scientific, Inc is the exclusive distributor for clinical customers in the US and select European countries.
Average Trading Volume: 1,952,823
Technical Sentiment Signal: Hold
Current Market Cap: A$65.67M
For a thorough assessment of CC5 stock, go to TipRanks’ Stock Analysis page.